We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Retrospective analysis shows infection rates in multiple myeloma patients treated with bispecific antibodies, indicating the need for effective prophylactic measures.
No takes yet. Share an insight, caveat, or question.
Cani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: